Cytori Therapeutics, Inc. (CYTX) Reports First Quarter 2013 Business and Financial Results
5/10/2013 7:38:47 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Cytori Therapeutics (NASDAQ: CYTX) today reports its first quarter 2013 financial results and provides updates on clinical development and commercialization activities.
For the first quarter of 2013, Cytori achieved $3.8 million in total revenue including $1.9 million in combined product and government contract revenue. Cytori reiterates guidance for the year of $15 million of product and contract revenue.
Help employers find you! Check out all the jobs and post your resume.
comments powered by